Tejara Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Sell |
107,337
-4,455
| -4% | -$132K | 1.47% | 25 |
|
|
2025
Q1 | $3.34M | Buy |
111,792
+83,011
| +288% | +$2.48M | 1.29% | 20 |
|
|
2024
Q4 | $825K | Buy |
+28,781
| New | +$825K | 0.54% | 40 |
|
|
2024
Q3 | – | Sell |
-124,700
| Closed | -$4.02M | – | 62 |
|
|
2024
Q2 | $4.02M | Buy |
+124,700
| New | +$4.02M | 1.46% | 24 |
|
|
2024
Q1 | – | Sell |
-141,099
| Closed | -$4.34M | – | 79 |
|
|
2023
Q4 | $4.34M | Sell |
141,099
-148,704
| -51% | -$4.58M | 1.82% | 21 |
|
|
2023
Q3 | $6.48M | Sell |
289,803
-14,886
| -5% | -$333K | 3.67% | 9 |
|
|
2023
Q2 | $6.55M | Buy |
304,689
+47,228
| +18% | +$1.01M | 3.22% | 9 |
|
|
2023
Q1 | $6.18M | Buy |
257,461
+136,681
| +113% | +$3.28M | 3.16% | 9 |
|
|
2022
Q4 | $2.8M | Buy |
+120,780
| New | +$2.8M | 1.61% | 18 |
|